Response to Diet and Metformin in Women With Idiopathic Intracranial Hypertension With and Without Concurrent Polycystic Ovary Syndrome or Hyperinsulinemia

Charles J Glueck MD, Karl C Golnik MD, Dawit Aregawi MD, Naila Goldenberg MD, Luann Sieve, BS, Ping Wang, PhD


In the current issue of Medscape General Medicine, Bagga and colleagues[1] review therapies for idiopathic intracranial hypertension (IIH) during pregnancy and suggest that "...most therapies used during non-pregnant state can also be used during pregnancy." One novel therapy that we have used successfully during pregnancy in 4 women with both IIH and polycystic ovary syndrome (PCOS) is glucophage, which is safe for both mother and fetus during pregnancy, is not teratogenic, and leads to a median average weight gain during pregnancy of zero pounds. Glucophage safely promoted weight loss in a predominantly morbidly obese cohort during pregnancy,[2,3,4,5,6,7,8,9,10,11] and thus was beneficial for IIH, particularly during pregnancy.

Our 2 previous studies revealed that 15 of 38 (39%)[12,13] and 37 of 65 (57%)[12] women referred solely for IIH had PCOS -- a prevalence 5 to 8 times higher than the 7% prevalence seen in the general unselected population.[14] Obesity is a clinical characteristic of both PCOS [15,16,17,18,19,20] and IIH.[21,22,23,24,25] The increased prevalence of PCOS in women with IIH speculatively reflects PCOS-driven morbid obesity, [15,16,17,18] which, in turn, facilitates development of IIH.[26]There are also links between obesity, PCOS, hypofibrinolysis, and thrombophilia.[15,16,17,18,27] Obesity, often with concurrent hyperinsulinemia and PCOS, is associated with hypofibrinolysis through elevation of plasminogen activator inhibitor activity (PAI-Fx).[15,16,17,18,28] Reduction of obesity by metformin in PCOS[15,16,17,18,28] and by gastric banding[29] lowers PAI-Fx. Obesity is also prothrombotic through its associations with high Factor VIII.[30] Obesity by itself is characterized by increased adipose tissue production of tumor necrosis factor-alfa and other prothrombotic pro-inflammatory adipokines.[31,32,33,34,35] Moreover, paradoxically high endogenous estrogens, common in PCOS[19] and in severe obesity,[36] are thrombophilic, and might play a role in the development of IIH, particularly in patients with coagulation disorders.[12,13,37]

After documentation of PCOS in women referred with IIH, the next step should be metformin (1.5-2.55 g/day) coupled with a calorie-restricted, high-protein, low-carbohydrate diet.[15,16,17,18] These interventions sharply lower weight, reduce insulin resistance, lower insulin-driven high PAI-Fx,[9,15,16,17,18] and reduce aromatization of testosterone, [19] diminishing testosterone conversion to estradiol[19] and thus reducing paradoxical hyperestrogenemia, which is also prothrombotic.

Weight loss has been shown to be the major catalyst for reduction of papilledema in women with IIH.[25] In a study of 15 obese women (mean BMI 40.7) with IIH, Johnson and colleagues[25] reported that "... an average of 3.3% weight loss (± 0.5% SEM) was observed in patients having a one-grade change in papilledema." Weight loss of 6.2% (± 0.6% SEM) had a 3-grade change in papilledema (complete resolution of marked papilledema).[25] No patient without weight loss had improvement in papilledema despite treatment with acetazolamide.[25] Because conventional therapy for IIH,[38] as in the report by Bagga and colleagues,[1] still leaves a substantial percentage of patients with headache[39]and a lesser percentage with persistent papilledema and visual field deficits,[40] any novel medical therapy should be welcome. We speculate that PCOS, associated with obesity and extreme obesity in adolescence and young adulthood,[9,15,16,17,18] is a treatable promoter[12,13] of IIH, since metformin effectively promotes weight loss in women with PCOS[16,17,18,41] and weight loss improves signs and symptoms of IIH[24,25,42] in patients with and without PCOS.[43]


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.